KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to -$1.5 million.

  • Exact Sciences' Cash from Financing Activities fell 57787.61% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$251.7 million, marking a year-over-year decrease of 20877.48%. This contributed to the annual value of $231.9 million for FY2024, which is 4513.35% up from last year.
  • As of Q3 2025, Exact Sciences' Cash from Financing Activities stood at -$1.5 million, which was down 57787.61% from -$4.5 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Cash from Financing Activities registered a high of $224.6 million during Q2 2024, and its lowest value of -$256.2 million during Q1 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was $2.7 million (2022), whereas its average is $11.3 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 478468.01% in 2023, then tumbled by 843334.44% in 2025.
  • Exact Sciences' Cash from Financing Activities (Quarter) stood at -$12.2 million in 2021, then soared by 182.84% to $10.1 million in 2022, then fell by 0.65% to $10.0 million in 2023, then increased by 4.6% to $10.5 million in 2024, then plummeted by 114.59% to -$1.5 million in 2025.
  • Its Cash from Financing Activities stands at -$1.5 million for Q3 2025, versus -$4.5 million for Q2 2025 and -$256.2 million for Q1 2025.